SCHEMBL4312980

SCHEMBL4312980

O=C(Nc1ccc(Cl)cn1)c1oc2ccccc2c1NC(=O)C1CCC(C(=O)O)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.62
▸ MEN1 O00255 5/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ POLB P06746 2/20 0.56
▸ RXFP1 Q9HBX9 2/20 0.56
▸ KDM4E B2RXH2 6/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ GAA P10253 1/20 0.54
▸ MAPT P10636 6/20 0.53
▸ TSHR P16473 5/20 0.53
▸ HSD17B10 Q99714 4/20 0.53
▸ HTT P42858 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TP53 P04637 4/20 0.51
▸ LMNA P02545 1/20 0.51
▸ DHODH Q02127 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4312968 1.00 KMT2A (0.62) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL13744493 0.91 SMN1; SMN2 (0.59) KMT2AMEN1SMN1; SMN2POLBRXFP1
Hydrochloric Acid SCHEMBL2943708 0.91 SMN1; SMN2 (0.58) KMT2AMEN1SMN1; SMN2POLBRXFP1
Hydrochloric Acid SCHEMBL2943711 0.91 SMN1; SMN2 (0.58) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL2949472 0.90 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL4318011 0.90 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL2949468 0.90 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL4318005 0.90 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL2944372 0.90 SMN1; SMN2 (0.59) KMT2AMEN1SMN1; SMN2POLBRXFP1
SCHEMBL13744688 0.89 SMN1; SMN2 (0.59) KMT2AMEN1SMN1; SMN2POLBRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 — — US disclosed
US-20060247273-A1 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-11-02 — — US disclosed
EP-1666478-A1 CARBAMOYL-TYPE BENZOFURAN DERIVATIVES TANABE SEIYAKU CO., LTD. (JP) 2006-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247273-A1 Carbamoyl-type benzofuran derivatives F12, F2, F3 KMT2A 60/4885MEN1 1937/4885SMN1; SMN2 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback